Search by Drug Name or NDC
NDC 14789-0102-02 Tirofiban Hydrochloride 50 ug/mL Details
Tirofiban Hydrochloride 50 ug/mL
Tirofiban Hydrochloride is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nexus Pharmaceuticals Inc.. The primary component is TIROFIBAN HYDROCHLORIDE.
Product Information
| NDC | 14789-0102 |
|---|---|
| Product ID | 14789-102_24bc52a7-a600-4896-b726-fe91e43e3f1e |
| Associated GPIs | |
| GCN Sequence Number | 064719 |
| GCN Sequence Number Description | tirofiban-0.9% sodium chloride PLAST. BAG 12.5MG/250 INTRAVEN |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 16186 |
| HICL Sequence Number | 018384 |
| HICL Sequence Number Description | TIROFIBAN HCL MONOHYDRATE IN 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Tirofiban Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tirofiban Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/mL |
| Substance Name | TIROFIBAN HYDROCHLORIDE |
| Labeler Name | Nexus Pharmaceuticals Inc. |
| Pharmaceutical Class | Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213947 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 14789-0102-02 (14789010202)
| NDC Package Code | 14789-102-02 |
|---|---|
| Billing NDC | 14789010202 |
| Package | 1 BAG in 1 CARTON (14789-102-02) / 250 mL in 1 BAG |
| Marketing Start Date | 2023-09-25 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |